ERBB2 and inflammatory breast carcinoma: The aim of this focused study is to validate a semi-automated computational model to assist in HER2 IHC interpretation using the QuantCenter (MembraneQuant) software developed by 3DHISTECH Ltd. (Budapest, Hungary) and provide a platform for larger studies going forward to aid in the subsequent HER2 classification and appropriate treatment of IBC.